ZYBT
Zhengye Biotechnology Holding Ltd (ZYBT)
Healthcare • NASDAQ • $0.95-2.87%
- Symbol
- ZYBT
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $0.95
- Daily Change
- -2.87%
- Market Cap
- $45.00M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $13.79
- 52W Low
- $0.68
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Company websiteResearch ZYBT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.